11/17
08:06 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $30.00.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $30.00.
11/17
06:11 am
advm
Adverum Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Adverum Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright
11/17
06:11 am
advm
Adverum Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Adverum Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright